Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer

Vladimir Avkshtol,Karen Ruth,Eric A. Ross,Mark A. Hallman,Richard E. Greenberg,Robert A. Price,B.K. Leachman,Robert G. Uzzo,Charlie Ma,David Y.T. Chen,Daniel M. Geynisman,Mark L. Sobczak,Eddie Zhang,J.K. Wong,Alan Pollack,Eric M. Horwitz

Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer

2020

Vladimir Avkshtol
Karen Ruth
Eric A. Ross
Mark A. Hallman
Richard E. Greenberg
Robert A. Price
B.K. Leachman
Robert G. Uzzo
Charlie Ma
David Y.T. Chen
Daniel M. Geynisman
Mark L. Sobczak
Eddie Zhang
J.K. Wong
Alan Pollack
Eric M. Horwitz

PURPOSEThe previously published single institution randomized prospective trial failed to show superiority in the 5-year biochemical and/or clinical disease failure (BCDF) rate with moderate hypofr...

Keywords:

Prostate cancer
Physical therapy
Oncology
clinical disease
Hypofractionated Radiation Therapy
Internal medicine
single institution
Medicine
prospective trial

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations